NEW YORK, SEPTEMBER 4, 2022 (GLOBE NEWSWIRE) — why: Rosen Law Firm, a global investor rights law firm, announced that Enochian BioSciences, Inc. (NASDAQ: ENOB) securities to the purchaser. Important notices on or about February 16, 2018 September 26, 2022 Principal plaintiff deadline.
So what: If you purchase Enochian BioSciences securities during the class period, you are entitled to compensation without having to pay copays or the cost of a contingency fee arrangement.
What next: To participate in the Enochian BioSciences class action lawsuit, please visit https://rosenlegal.com/submit-form/?case_id=6517 or call Esq. Phillip Kim. For class action information, please call toll-free 866-767-3653 or email firstname.lastname@example.org or email@example.com. A class action lawsuit has already been filed.If you want to act as the lead plaintiff, you must go to court Until September 26, 2022A principal plaintiff is a representative party acting on behalf of other class members in directing a litigation.
Reasons for adopting the Rosen method: Investors are encouraged to select a qualified attorney with a successful track record in leadership roles. Companies issuing notices often do not have comparable experience, resources, or meaningful peer recognition. Many of these law firms do not actually handle securities class action lawsuits, but are merely intermediaries that refer clients or are affiliated with the law firms that actually litigate. Choose your counselors wisely. Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivative actions. Rosen Law Firm Achieves Largest Securities Class Action Settlement Against Chinese Company Ever. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The company has ranked in his top four every year since 2013, and has collected hundreds of millions of dollars for its investors. In 2019 alone, the company secured more than $438 million of his for investors. In 2020, founding partner Lawrence Rosen was named a Giant of the Plaintiffs Bar Association by law360. Many of our attorneys are certified by Lawdragon and Super Lawyers.
Case details: According to the lawsuit, defendants during the class period made false and/or misleading statements and/or failed to disclose: (2) Gumrukcu was not a licensed physician anywhere in the world. (3) As a result of the foregoing, Gumrukcu’s alleged contribution to the Enochians lacked a rational basis. (4) As a result of the above, Enochian exaggerated its commercial prospects. (5) Gumrukcu had improperly diverted approximately $20 million from his Enochian to an entity he owned. (6) As a result of the foregoing, defendant’s positive statements regarding Enochian’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When it entered the market, the lawsuit alleges that investors suffered losses.
To participate in the Enochian BioSciences class action lawsuit, please visit https://rosenlegal.com/submit-form/?case_id=6517 or call Esq. Phillip Kim. For class action information, please call toll-free 866-767-3653 or email firstname.lastname@example.org or email@example.com.
There are no accredited classes. You will not be represented by an attorney unless you hold an attorney until your class is certified. You can choose your preferred contact point. You can also remain an absent class member and do nothing at this time. An investor’s ability to share in potential future recoveries is not dependent on serving as a primary plaintiff.
For the latest on LinkedIn, visit https://www.linkedin.com/company/the-rosen-law-firm and follow us on Twitter. https://twitter.com/rosen_firm Or Facebook: https://www.facebook.com/rosenlawfirm/.
Advertisement for lawyers. Previous results are no guarantee of similar results.
Lawrence Rosen, Esq.
Mr. Philip Kim
Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, New York 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827